Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03851484 · ClinicalTrials.gov registry record
Sensory Symptoms in Tourette Syndrome
A clinical trial of Tourette Syndrome, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- 214
- Enrollment target
- 2
- Study locations
NCT03851484: Recruiting study of Tourette Syndrome, sponsored by Vanderbilt University Medical Center.
NCT03851484 is a study of Tourette Syndrome that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 214 participants, above the 80-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (168% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03851484, a study of Tourette Syndrome, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- 214 participants
- Enrollment target
- 2
- Study locations
Study Summary
Patients with tics will be asked to complete a series of validated questionnaires (in electronic and/or paper format) regarding symptoms and conditions often associated with Tourette syndrome, including premonitory urges, sensory experiences, inattention, obsessive-compulsive tendencies, anxiety, and depression. Participants will also be asked to complete a quality of life assessment. This series of questionnaires will be administered annually.
Primary Outcome
Validated instrument assessing anomalous sensory experiences. Scale consists of 35 items screening patients for hyper- or hypo-sensitivity to each of the sensory domains (touch, sight, sound, smell, and taste). Each scale item is a statement to which participants provide a ranking: 0 = strongly agree 1. = agree 2. = disagree 3. = strongly disagree The minimum score on the short from is 0; the maximum score is 140. Higher scores indicate more abnormal sensory experiences.
Conditions Studied
Study Locations (2)
Tennessee
- Vanderbilt University Medical Center - Nashville
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2019-04-17 |
| Est. Completion | 2028-12-31 |
What NCT03851484 shows while recruiting
NCT03851484 is an observational study that tracks outcomes without assigning an intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, above the 80-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (168% higher).
The record links to 1 condition, with Tourette Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT03851484 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03851484 about?
NCT03851484 is a clinical study titled "Sensory Symptoms in Tourette Syndrome". Patients with tics will be asked to complete a series of validated questionnaires (in electronic and/or paper format) regarding symptoms and conditions often associated with Tourette syndrome, including premonitory urges, sensory experiences, inattention, obsessive-compulsive tendencies, anxiety, an...
What is the current status of trial NCT03851484?
This trial is currently recruiting. The enrollment target is 214 participants. The study started on 2019-04-17. Estimated completion is 2028-12-31.
What conditions does trial NCT03851484 study?
This clinical trial studies the following conditions: Tourette Syndrome.
Who is sponsoring clinical trial NCT03851484?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03851484 being conducted?
This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tourette Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03851484's enrollment target sits among peer trials
214 4th of 33 higher than 30 of 33 other Tourette Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tourette Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
RECRUITING
-
Remote Delivery of a Mindfulness-based Intervention for Tics
RECRUITING · NA
-
Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for Tics
RECRUITING · Phase 2
-
Trajectories of Change in Tourette Syndrome
RECRUITING · NA
-
Longitudinal Impact of Stressors in Adults With Tourette Syndrome
RECRUITING
-
Clinical Characteristics and Temporal Properties of Individual Tics in Persistent Tic Disorder
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI